SCHEMBL4866570

SCHEMBL4866570

O=C1C=C(COCc2ccccc2)CC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.54
POLB P06746 1/20 0.39
HTT P42858 1/20 0.39
DAO P14920 1/20 0.39
LMNA P02545 1/20 0.39
CYP3A4 P08684 1/20 0.38
ALOX15 P16050 1/20 0.38
MAOA P21397 2/20 0.38
MAOB P27338 2/20 0.38
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
APH1B Q8WW43 1/20 0.37
NCSTN Q92542 1/20 0.37
APH1A Q96BI3 1/20 0.37
PSENEN Q9NZ42 1/20 0.37
APP P05067 1/20 0.37
CYP2C19 P33261 1/20 0.37
IDO1 P14902 1/20 0.36
HTR2B P41595 1/20 0.35
AGXT P21549 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6517311 0.76 POLB (0.42) POLBHTTDAOALOX15MAOA
SCHEMBL9725547 0.76 TSHR (0.94) TSHRPOLBLMNACYP2C19IDO1
SCHEMBL28713802 0.73 TSHR (0.62) TSHRPOLBCYP3A4ALOX15CYP2C19
SCHEMBL27380 0.73 TSHR (1.00) TSHRPOLBLMNACYP2C19IDO1
Benzene SCHEMBL27997624 0.73 TSHR (1.00) TSHRPOLBLMNACYP2C19IDO1
SCHEMBL5311581 0.73 TSHR (1.00) TSHRPOLBLMNACYP2C19IDO1
SCHEMBL9609521 0.73 HTT (0.56) TSHRPOLBHTTLMNAMAOA
Cyclohexane SCHEMBL8149682 0.71 TSHR (0.83) TSHRPOLBLMNAIDO1AGXT
Methoxymethane SCHEMBL27428029 0.71 TSHR (0.83) TSHRPOLBMAOBIDO1AGXT
SCHEMBL28301231 0.71 TSHR (0.83) TSHRPOLBDAOIDO1AGXT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080125310-A1 Hydride reduction of alpha, beta-unsaturated carbonyl compounds using chiral organic catalysts CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2008-05-29 US disclosed
US-7323604-B2 Hydride reduction of α,β-unsaturated carbonyl compounds using chiral organic catalysts CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2008-01-29 US disclosed
US-20060161024-A1 Hydride reduction of alpha, beta-unsaturated carbonyl compounds using chiral organic catalysts CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2006-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060161024-A1 Hydride reduction of alpha, beta-unsaturated carbonyl compounds using chiral organic catalysts ECH1, CBR1, DHCR24 TSHR 4819/4885POLB 973/4885HTT 1747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.